1277 Results for: "MEDCHEMEXPRESS"
Glial-cell-line-derived neurotrophic factor (GDNF), a neurotrophic factor belongs to the GDNF family ligands (GFLs)., promotes survi val of dopamine neurons. GDNF demonstrates a variety of neuroprotective roles for mammalian neurons[1]. GDNF Protein, 1 * 2 µG
Supplier: MEDCHEMEXPRESS
Glial-cell-line-derived neurotrophic factor (GDNF), a neurotrophic factor belongs to the GDNF family ligands (GFLs)., promotes survi val of dopamine neurons. GDNF demonstrates a variety of neuroprotective roles for mammalian neurons[1]. GDNF Protein, 1 * 2 µG
Expand 1 Items
RapaLink-1, the third-generation bivalent mTOR inhibitor, combines Rapamycin (HY-10219) with MLN0128 (HY-13328, a second-generation mTOR kinase inhibitor) by an inert chemical linker. RapaLink-1 shows better efficacy than Rapamycin or mTOR kinase inh 1 * 10 mg
Supplier: MEDCHEMEXPRESS
RapaLink-1, the third-generation bivalent mTOR inhibitor, combines Rapamycin (HY-10219) with MLN0128 (HY-13328, a second-generation mTOR kinase inhibitor) by an inert chemical linker. RapaLink-1 shows better efficacy than Rapamycin or mTOR kinase inh 1 * 10 mg
Expand 1 Items
BAI1 is a selective and allosteric inhibitor of BAX, an apoptosis regulator. BAI1 directly binds to BAX and allosterically inhibits BAX activation. BAI1 has the potential for the research of diseases mediated by BAX-dependent cell death[1]. 1 * 5 mg
Supplier: MEDCHEMEXPRESS
BAI1 is a selective and allosteric inhibitor of BAX, an apoptosis regulator. BAI1 directly binds to BAX and allosterically inhibits BAX activation. BAI1 has the potential for the research of diseases mediated by BAX-dependent cell death[1]. 1 * 5 mg
Expand 1 Items
Foretinib is a multi-target tyrosine kinase inhibitor with IC50s of 0.4 nM and 0.9 nM for Met and KDR. 1 * 5 mg
Supplier: MEDCHEMEXPRESS
Foretinib is a multi-target tyrosine kinase inhibitor with IC50s of 0.4 nM and 0.9 nM for Met and KDR. 1 * 5 mg
Expand 1 Items
C646 is a selective and competitive histone acetyltransferase p300 inhibitor with Ki of 400 nM, and is less potent for other acetylt ransferases[1]. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
C646 is a selective and competitive histone acetyltransferase p300 inhibitor with Ki of 400 nM, and is less potent for other acetylt ransferases[1]. 1 * 10 mg
Expand 1 Items
Bisindolylmaleimide I (GF109203X) is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I is also a GSK-3 inhibitor[1][2][3]. 1 * 50 mg
Supplier: MEDCHEMEXPRESS
Bisindolylmaleimide I (GF109203X) is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I is also a GSK-3 inhibitor[1][2][3]. 1 * 50 mg
Expand 1 Items
(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) is a potent, selective and irreversible NF-κB inhibitor that covalently binds to a cystei ne residue. (-)-DHMEQ inhibits nuclear translocation of NF-κB and shows anti-inflammatory and anticancer activity[1][ 1 * 10 mg
Supplier: MEDCHEMEXPRESS
(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) is a potent, selective and irreversible NF-κB inhibitor that covalently binds to a cystei ne residue. (-)-DHMEQ inhibits nuclear translocation of NF-κB and shows anti-inflammatory and anticancer activity[1][ 1 * 10 mg
Expand 1 Items
STING agonist-4 ,98% 1 * 10 mg
Supplier: MEDCHEMEXPRESS
STING agonist-4 ,98% 1 * 10 mg
Expand 1 Items
Fmoc-3VVD-OH(Purity 98%) 1 * 1 g
Supplier: MEDCHEMEXPRESS
Fmoc-3VVD-OH(Purity 98%) 1 * 1 g
Expand 1 Items
Skp2 inhibitor 1 (1 mg) 1 * 1 mg
Supplier: MEDCHEMEXPRESS
Skp2 inhibitor 1 (1 mg) 1 * 1 mg
Expand 1 Items
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide has the potential for type 2 diabetes treatment. 1 * 1 mg
Supplier: MEDCHEMEXPRESS
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide has the potential for type 2 diabetes treatment. 1 * 1 mg
Expand 1 Items
AZD3965 is a selective MCT1 inhibitor with a Ki of 1.6 nM, showing 6-fold selectivity over MCT2. 1 * 100 mg
Supplier: MEDCHEMEXPRESS
AZD3965 is a selective MCT1 inhibitor with a Ki of 1.6 nM, showing 6-fold selectivity over MCT2. 1 * 100 mg
Expand 1 Items
Simvastatin (MK 733) is a competitive inhibitor of HMG-CoA reductase with a Ki of 0.2 nM. 1 * 5 mg
Supplier: MEDCHEMEXPRESS
Simvastatin (MK 733) is a competitive inhibitor of HMG-CoA reductase with a Ki of 0.2 nM. 1 * 5 mg
Expand 1 Items
SP600125 is an orally active, reversible, and ATP-competitive JNK inhibitor with IC50s of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively. SP600125 is a potent ferroptosis inhibitor. SP600125 induces the transformation of bladder cancer cells 1 * 200 mg
Supplier: MEDCHEMEXPRESS
SP600125 is an orally active, reversible, and ATP-competitive JNK inhibitor with IC50s of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively. SP600125 is a potent ferroptosis inhibitor. SP600125 induces the transformation of bladder cancer cells 1 * 200 mg
Expand 1 Items
PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM Ki=5.9 nM). PLX5622 allows for exten ded and specific microglial cells elimination, preceding and during pathology development. PLX5622 demonstrates desir 1 * 100 mg
Supplier: MEDCHEMEXPRESS
PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM Ki=5.9 nM). PLX5622 allows for exten ded and specific microglial cells elimination, preceding and during pathology development. PLX5622 demonstrates desir 1 * 100 mg
Expand 1 Items
Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM)[1]. 1 * 100 mg
Supplier: MEDCHEMEXPRESS
Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM)[1]. 1 * 100 mg
Expand 1 Items
Wortmannin (SL-2052 KY-12420) is a potent, selective and irreversible PI3K inhibitor with an IC50 of 3 nM. Wortmannin also blocks a utophagy formation, and potently inhibits Polo-like kinase 1 (PlK1) and Plk3 with IC50s of 5.8 and 48 nM, respectivel 1 * 100 mg
Supplier: MEDCHEMEXPRESS
Wortmannin (SL-2052 KY-12420) is a potent, selective and irreversible PI3K inhibitor with an IC50 of 3 nM. Wortmannin also blocks a utophagy formation, and potently inhibits Polo-like kinase 1 (PlK1) and Plk3 with IC50s of 5.8 and 48 nM, respectivel 1 * 100 mg
Expand 1 Items
Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IF N-α. 1 * 50 mg
Supplier: MEDCHEMEXPRESS
Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IF N-α. 1 * 50 mg
Expand 1 Items
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, resp ectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting 1 * 100 mg
Supplier: MEDCHEMEXPRESS
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, resp ectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting 1 * 100 mg
Expand 1 Items
Ulixertinib (BVD-523 VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of [1][2]. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
Ulixertinib (BVD-523 VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of [1][2]. 1 * 10 mg
Expand 1 Items
Rucaparib (AG014699) is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP 1. Rucaparib is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib has the potential for castratio 1 * 50 mg
Supplier: MEDCHEMEXPRESS
Rucaparib (AG014699) is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP 1. Rucaparib is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib has the potential for castratio 1 * 50 mg
Expand 1 Items
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan s hows anticancer activity[1]. 1 * 1 mg
Supplier: MEDCHEMEXPRESS
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan s hows anticancer activity[1]. 1 * 1 mg
Expand 1 Items
Fedratinib (TG-101348) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces 1 * 100 mg
Supplier: MEDCHEMEXPRESS
Fedratinib (TG-101348) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces 1 * 100 mg
Expand 1 Items
Subasumstat (TAK-981) is a first in class and selective inhibitor of the SUMOylation enzymatic cascade, with potential immune-activa ting and antineoplastic activities[1][2]. 1 * 100 mg
Supplier: MEDCHEMEXPRESS
Subasumstat (TAK-981) is a first in class and selective inhibitor of the SUMOylation enzymatic cascade, with potential immune-activa ting and antineoplastic activities[1][2]. 1 * 100 mg
Expand 1 Items
Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor[1][ 1 * 50 mg
Supplier: MEDCHEMEXPRESS
Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor[1][ 1 * 50 mg
Expand 1 Items
Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC50 of 0.6 nM. Brigatinib can be used for research of NSCLC[1]. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC50 of 0.6 nM. Brigatinib can be used for research of NSCLC[1]. 1 * 10 mg
Expand 1 Items
CC-885 is a cereblon (CRBN) modulator with potent anti-tumour activity. CC-885 is also a known degrader of GSPT1, inhibiting protein translation. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
CC-885 is a cereblon (CRBN) modulator with potent anti-tumour activity. CC-885 is also a known degrader of GSPT1, inhibiting protein translation. 1 * 10 mg